Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD
Clinical trial NCT03673670 · COMPLETED
Trial details
- NCT number
- NCT03673670
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-16
- Primary completion
- 2018-11-13
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.